• Home

Home > Medical Reference > Patient Education

• Highlights
• Introduction
• Symptoms
• Causes and Risk Factors
• Triggers
• Diagnosis
• Treatment: Medications
• Other Treatments
• Lifestyle Changes
• Complications
• Resources
• References

Gout

Description

An in-depth report on the causes, diagnosis, treatment, and prevention of gout.

Alternative Names

Hyperuricemia

References

Huang HY, Appel LJ, Choi MJ et al. The effects of vitamin C supplementation on serum concentrations of uric acid: results of a randomized controlled trial. Arthritis Rheum . 2005 Jun;52(6):1843-7.

Chen VC, Ho PL, Yuen KY. Two probable cases of serious drug interaction between clarithromycin and colchicine. South Med J . 2005 Aug;98(8):811-3.

Saxena R, Loghmanee F. Fatal drug reaction due to allopurinol therapy in a 72-year-old man. Arch Pathol Lab Med. 2005 Aug;129(8):e183-4.

Tsutsumi Z. Oxidized low-density lipoprotein autoantibodies in patients with primary gout: effect of urate-lowering therapy. Clin Chim Acta - 01-JAN-2004; 339(1-2): 117-22.

Bardin T. Current management of gout in patients unresponsive or allergic to allopurinol. Joint Bone Spine . 2004; 71(6):481-5.

Akkasilpa S. The efficacy of combined low dose of Allopurinol and benzbromarone compared to standard dose of Allopurinol in hyperuricemia. J Med Assoc Thai. 2004; 87(9): 1087-91.

Russmann S. Life-threatening adverse effects of pharmacologic antihyperuricemic therapy. Ther Umsch . 2004; 61(9):575-7.

YQ Zhang, Chaisson CE, Chen CA, McAlindon TE, Hunter DJ. High Humidity and High Temperature Increase the Risk of Recurrent Gout Attacks: The Online Case-crossover Gout Study. Presentation Number 707. American College of Rheumatology Annual Scientific Meeting, Washington, DC, November 2006.

Wu EQ, Mody RR, Krishnan E, et al. Tighter Control of Serum Uric Acid in Gout is Associated with Lower Morbidity and Health Care Costs. Presentation Number 736. American College of Rheumatology Annual Scientific Meeting, Washington, DC, November 2006.

Krishnan E, Baker JF, Furst DE, Schumacher HR. Gout and the risk of acute myocardial infarction. Arthritis Rheum . 2006 Aug;54(8):2688-96.

Ganson NJ, Kelly SJ, Scarlett E, Sundy JS, Hershfield MS. Control of hyperuricemia in subjects with refractory gout, and induction of antibody against poly(ethylene) glycol (PEG), in a phase I trial of subcutaneous PEGylated urate oxidase. Arthritis Res Ther . 2005 Dec 2;8(1):R12 [Epub ahead of print].

• Review Date: 11/30/2006
• Reviewed By: Harvey Simon, MD, Associate Professor of Medicine, Harvard Medical School; Physician, Massachusetts General Hospital

A.D.A.M., Inc. is accredited by URAC, also known as the American Accreditation HealthCare Commission (www.urac.org). URAC's accreditation program is the first of its kind, requiring compliance with 53 standards of quality and accountability, verified by independent audit. A.D.A.M. is among the first to achieve this important distinction for online health information and services. Learn more about A.D.A.M.'s editorial process . A.D.A.M. is also a founding member of Hi-Ethics (www.hiethics.com) and subscribes to the principles of the Health on the Net Foundation (www.hon.ch).

The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed medical professional should be consulted for diagnosis and treatment of any and all medical conditions. Call 911 for all medical emergencies. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. © 1997-2007 A.D.A.M., Inc. Any duplication or distribution of the information contained herein is strictly prohibited.